Bioneer Corporation (established in 1992) is the first and currently leading biotech company in South Korea. We have over 20 years of continuous R&D and approximately 440 patents applied and registered. Bioneer has accumulated vast proprietary technology and developmental capability to venture into the world of molecular diagnostics (MDx). Bioneer do not confine only to development of reagents. We have developed state-of-the-art molecular biology products and fully equipped automatic instruments – including novel enzyme technologies, nucleic-acid extraction instruments, thermal cycler, real-time qPCR, MDx workstations and etc. We will also continue to develop novel next-generation systems to accommodate continuously growing demands in the MDx market and to be the world's best MDx company.